BIRC5 and breast carcinoma: Nuclear survivin expression is associated with lower OS and progression-free survival.[36] Liu et al divided 142 breast cancer patients into triple-negative and non-triple-negative groups, assessing nuclear and cytoplasmic survivin expression by IHC.